Cargando…
Damage in the Multiethnic Malaysian Systemic Lupus Erythematosus (SLE) Cohort: Comparison with Other Cohorts Worldwide
Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease and despite the improvement in the survival in the past few decades, the morbidity due to disease damage remains significant. The objectives of this study were to investigate the disease damagepattern and determine the associated fac...
Autores principales: | Shaharir, Syahrul Sazliyana, Hussein, Heselynn, Rajalingham, Sakthiswary, Mohamed Said, Mohd Shahrir, Abdul Gafor, Abdul Halim, Mohd, Rozita, Mustafar, Ruslinda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5112785/ https://www.ncbi.nlm.nih.gov/pubmed/27846298 http://dx.doi.org/10.1371/journal.pone.0166270 |
Ejemplares similares
-
Risk factors for symptomatic Avascular Necrosis (AVN) in a multi-ethnic Systemic Lupus Erythematosus (SLE) cohort
por: Shaharir, Syahrul Sazliyana, et al.
Publicado: (2021) -
Predictors of SLE relapse in pregnancy and post-partum among multi-ethnic patients in Malaysia
por: Shaharir, Syahrul Sazliyana, et al.
Publicado: (2019) -
Role of febuxostat in retarding progression of diabetic kidney disease with asymptomatic hyperuricemia: A 6-months open-label, randomized controlled trial
por: Mukri, Mohd Noor Azreey, et al.
Publicado: (2018) -
Frequency and Clinical Significance of Elevated IgG4 in Rheumatoid Arthritis: A Systematic Review
por: Sakthiswary, Rajalingham, et al.
Publicado: (2022) -
Rheumatoid Arthritis: Refractory to Infliximab, a Tumor Necrosis Factor Inhibitor
por: Solehan, Hana Maizuliana bt, et al.
Publicado: (2011)